Seqirus UK
Chemicals & Related Products · Australia · 11-50 Employees
View Company Info for Free
Overview
Headquarters
63 Australia, Parkville, Victoria, 3052,...Phone Number
+61 1800008275Website
www.seqirus.com.auRevenue
$17.4 MillionIndustry
About Seqirus UK
CSL Seqirus is a global influenza vaccine company that focuses on the prevention of influenza and pandemic preparedness. Created in 2015 when parent company CSL Limited acquired the Novartis influenza vaccine business and combined it with bioCSL, the company operates manufacturing plants in the US, UK, and Australia. It utilizes both egg and cell-based production technologies to provide a portfolio of influenza vaccines, including quadrivalent vaccines and the only adjuvanted seasonal influenza vaccine for older adults and paediatrics. The company serves global public health needs through a globally integrated supply chain and research into vaccine effectiveness and manufacturing processes.Explore more
Seqirus UK Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Seqirus UK
Compare insights from companies similar to Seqirus UK, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Seqirus UK
$17.4M
11-50
Private
-
2015
CF
Christine FarquharsonDirector, Federal Policy & Government Affairs
Seqirus UK Tech Stack
A closer look at the technologies used by Seqirus UK
See more technologies
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Seqirus UK
Sign Up For FreeTo access detailed company insights
CSL Seqirus is a global influenza vaccine company that focuses on the prevention of influenza and pandemic preparedness. Created in 2015 when parent company CSL Limited acquired the Novartis influenza vaccine business and combined it with bioCSL, the company operates manufacturing plants in the US, UK, and Australia. It utilizes both egg and cell-b... Read More
